WH
Wende Hutton
General Partner at Canaan Partners
Menlo Park, California
Overview
Wende Hutton is a General Partner at Canaan Partners in Menlo Park, California, with a background in investing in sectors such as Pharmaceuticals, BioTech, and Health IT. She has made significant investments in companies like Qlaris Bio and Glooko, showcasing her expertise in identifying and supporting innovative startups in the healthcare industry.
Work Experience
General Partner
2004 - Current
Investor in Med tech/Digital Health and Biopharmaceuticals. Recent boards include Labrys Biologics (acquired by Teva), Dermira (DERM), Transcend Medical (acquired by Alcon/Novartis) and Chimerix (CMRX). Current boards include Antiva Biosciences, Glooko, OncoResponse, Qlaris Bio and Hyalex Orthopeadics.
Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.
supporter
2013 - 2013
General Partner
1993 - 2001
Mayfield is an early-stage VC firm investing in enterprise, deeptech, and human and planetary health companies.
General Manager, Transgenic Lab Products
1991 - 1992
Director, International Business Unit; Dir of Business Development; Marketing
1986 - 1990